↓ Skip to main content

Treatment of bloodstream infections in ICUs

Overview of attention for article published in BMC Infectious Diseases, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
3 X users
googleplus
1 Google+ user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of bloodstream infections in ICUs
Published in
BMC Infectious Diseases, November 2014
DOI 10.1186/1471-2334-14-489
Pubmed ID
Authors

Jean-François Timsit, Jean-François Soubirou, Guillaume Voiriot, Sarah Chemam, Mathilde Neuville, Bruno Mourvillier, Romain Sonneville, Eric Mariotte, Lila Bouadma, Michel Wolff

Abstract

Bloodstream infections (BSIs) are frequent in ICU and is a prognostic factor of severe sepsis. Community acquired BSIs usually due to susceptible bacteria should be clearly differentiated from healthcare associated BSIs frequently due to resistant hospital strains. Early adequate treatment is key and should use guidelines and direct examination of samples performed from the infectious source. Previous antibiotic therapy knowledge, history of multi-drug resistant organism (MDRO) carriage are other major determinants of first choice antimicrobials in heathcare-associated and nosocomial BSIs. Initial antimicrobial dose should be adapted to pharmacokinetic knowledge. In general, a high dose is recommended at the beginning of treatment. If MDRO is suspected combination antibiotic therapy is mandatory because it increase the spectrum of treatment. Most of time, combination should be pursued no more than 2 to 5 days.Given the negative impact of useless antimicrobials, maximal effort should be done to decrease the antibiotic selection pressure. De-escalation from a broad spectrum to a narrow spectrum antimicrobial decreases the antibiotic selection pressure without negative impact on mortality. Duration of therapy should be shortened as often as possible especially when organism is susceptible, when the infection source has been totally controlled.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Unknown 158 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 17%
Student > Bachelor 23 14%
Student > Postgraduate 14 9%
Other 13 8%
Researcher 13 8%
Other 26 16%
Unknown 43 27%
Readers by discipline Count As %
Medicine and Dentistry 51 32%
Agricultural and Biological Sciences 13 8%
Immunology and Microbiology 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 10 6%
Biochemistry, Genetics and Molecular Biology 8 5%
Other 20 13%
Unknown 47 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2018.
All research outputs
#1,356,967
of 22,771,140 outputs
Outputs from BMC Infectious Diseases
#311
of 7,668 outputs
Outputs of similar age
#19,983
of 361,884 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 195 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,668 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,884 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.